Basic information
- CAS
32527-55-2- Standard SMILES
O=C(Cn1c(=O)sc2ccc(Cl)cc21)N1CCN(CCO)CC1- InChIKey
HTJXMOGUGMSZOG-UHFFFAOYSA-N- Molecular formula
- C15H18ClN3O3S
- Average molar mass
- 355.8 g/mol
- Monoisotopic mass
- 355.0757403
Overview
Tiaramide is a member of benzothiazoles.
Names & identifiers
- Preferred name
- Tiaramide
- IUPAC
- 5-chloro-3-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-2-oxoethyl]-1,3-benzothiazol-2-one
- English name
- Tiaramide
- Molecular formula
- C15H18ClN3O3S
- Molecular weight
- 355.84
Names & synonyms
TIARAMIDE32527-55-2tialamideTiaramidaRHC 2592ATiaramidumBB17WGM686RHC-2592ADTXSID00236664-((5-Chloro-2-oxo-3(2H)-benzothiazolyl)acetyl)-1-piperazineethanolRefChem:189953DTXCID703666
Show more names
NTA-194Brn 1030245Einecs 251-083-7Tiaramide USP/EP/BP4-[(5-Chloro-2-oxobenzothiazol-3-yl)acetyl]-1-piperazineethanol4-[(5-Chloro-2-oxo-3(2H)-benzothiazolyl)acetyl]piperazine-1-ethanol
251-083-7USV 25925-chloro-3-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-2-oxoethyl]-1,3-benzothiazol-2-oneTiaramide (INN)TIARAMIDE [INN]Tiaramide [INN:BAN]Tiaramidum [INN-Latin]Tiaramida [INN-Spanish]
Database identifiers
- CAS
32527-55-2- PubChem CID
- 5469
- DTXSID
DTXSID0023666- ChEMBL
CHEMBL274239- ChEBI
CHEBI:135504
Properties
Computed structural properties
- XLogP
- 1
- Topological polar surface area
- 89.4 Ų
- Hydrogen bond donors
- 1
- Hydrogen bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 23
- Formal charge
- 0
- Complexity
- 459
Experimental & physicochemical properties
LogP1.04
Physicochemical properties
- Melting point
- 159 · 159-161 °C
- Boiling point
- 605.8 · 605.8±65.0 °C(Predicted)
- Density
- 1.432 · 1.432±0.06 g/cm3(Predicted)
- pka
- 6.2 · 6.2(at 25℃)
- EWG's Food Scores
- 1 · 1
- FDA UNII
- 17 WGM686 · BB17WGM686
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
Upstream & downstream products
Upstream raw materials
Suppliers10 total
毕佳索（上海毕得医药科技股份有限公司）400-6005915 · [email protected]
江苏艾康生物医药研发有限公司025-58851090 19370895928 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
湖北扬信医药科技有限公司0714-3999001 19171453112 · [email protected]
成都卡麦尔医药科技有限公司028-67136579 15828051124 · [email protected]
上海捷世凯生物科技有限公司021-57520305 13795461237 · [email protected]
重庆卡兰医药有限公司[email protected]
Related reactions
0 records
No reaction records under the current filter.
Compound notes
Loading…